Related Experiment Video
Updated: Jan 10, 2026
09:27
Sequential Extraction of Soluble and Insoluble Alpha-Synuclein from Parkinsonian Brains
Published on: January 5, 2016
18.0K
Nuclear Alpha-Synuclein: Mechanisms and Implications for Synucleinopathies
Tiago Fleming Outeiro1,2, David J Koss3
1Department of Experimental Neurodegeneration, Center for Biostructural Imaging of Neurodegeneration, University Medical Center Göttingen, Göttingen, Germany.
Movement Disorders : Official Journal of the Movement Disorder Society
|November 26, 2025
Summary
Alpha-synuclein protein moves into neuronal nuclei, impacting DNA and aging, potentially driving Parkinson's disease. Targeting nuclear alpha-synuclein offers new therapeutic and biomarker strategies for synucleinopathies.
Area of Science:
- Neuroscience
- Molecular Biology
- Genetics
Background:
- Alpha-synuclein (aSyn) is known for synaptic roles and Lewy bodies in Parkinson's disease (PD).
- Emerging evidence highlights aSyn's nuclear functions relevant to neurodegeneration.
- Nuclear aSyn's role in genomic stability and DNA repair is under investigation.
Purpose of the Study:
- To explore the nuclear activities of alpha-synuclein in health and disease.
- To investigate the mechanisms by which nuclear aSyn contributes to neurodegeneration.
- To assess the potential of nuclear aSyn as a biomarker and therapeutic target for synucleinopathies.
Main Methods:
- Utilized experimental models to study nuclear aSyn localization and function.
- Investigated aSyn interactions with chromatin, DNA, and DNA repair machinery.
- Employed advanced immunohistochemical and molecular techniques for detection in human tissues.
Main Results:
- Nuclear aSyn dynamically localizes to neurons in both healthy and diseased states.
- Nuclear aSyn, particularly phosphorylated or oligomeric forms, promotes neurodegeneration.
- Dysregulation of transcription, DNA repair deficits, and cellular senescence are linked to nuclear aSyn.
Conclusions:
- Nuclear aSyn plays a critical role in the pathogenesis of Parkinson's disease and related disorders.
- Nuclear aSyn represents a potential biomarker for disease stratification.
- Targeting nuclear aSyn pathways offers novel therapeutic strategies for synucleinopathies.
Related Concept Videos
01:37Neural Regulation
43.0K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
43.0K
03:03Amyloid Fibrils
11.5K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
11.5K
03:03Amyloid Fibrils
6.3K
6.3K
01:15Parkinson's Disease: Overview
1.7K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.7K
01:45Regulation of Nuclear Protein Sorting
3.2K
Nuclear protein sorting regulates nucleus composition and gene expression, crucial for determining the fate of a eukaryotic cell. Hence, the entry and exit of molecules across the nuclear envelope is a tightly controlled process. Nuclear protein sorting can be inhibited by one of the following ways: 1) masking cargo signal sequences, 2) modifying the nuclear receptor's affinity for cargo, 3) controlling the nuclear pore size, 4) retaining the cargo during its transit to the cytosol or the...
3.2K
01:48ATP Synthase: Mechanism
16.6K
In animals, the mitochondrial F1F0 ATP synthase is the key protein that synthesizes ATP molecules through a complex catalytic mechanism. While the nuclear genome encodes the majority of ATP synthase subunits, the mitochondrial genome encodes some of the enzyme's most critical components. The formation of this multi-subunit enzyme is a complex multi-step process regulated at the level of transcription, translation, and assembly. Defects in one or more of these steps can result in decreased...
16.6K